225 related articles for article (PubMed ID: 3595732)
1. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
[TBL] [Abstract][Full Text] [Related]
2. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.
Flueck JA; Di Bella FP; Edis AJ; Kehrwald JM; Arnaud CD
J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
Gautvik KM; Gautvik VT; Halvorsen JF
Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
Hackeng WH; Lips P; Netelenbos JC; Lips CJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
[TBL] [Abstract][Full Text] [Related]
5. The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism.
Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
Exp Clin Endocrinol; 1987 Dec; 90(3):324-30. PubMed ID: 3450531
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hypocalcemia with a highly sensitive, homologous radioimmunoassay for the midregion of parathyroid hormone.
Mallette LE; Wilson DP; Kirkland JL
Pediatrics; 1983 Jan; 71(1):64-9. PubMed ID: 6848981
[TBL] [Abstract][Full Text] [Related]
7. Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay.
Lindall AW; Elting J; Ells J; Roos BA
J Clin Endocrinol Metab; 1983 Nov; 57(5):1007-14. PubMed ID: 6311857
[TBL] [Abstract][Full Text] [Related]
8. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
Hortling L; Puutula-Räsänen L; Fyhrquist F
Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay for human parathyroid hormone for differentiation between patients with hypoparathyroidism, hyperparathyroidism and normals.
Streibl W; Minne H; Raue F; Ziegler R
Horm Metab Res; 1979 May; 11(5):375-6. PubMed ID: 478433
[TBL] [Abstract][Full Text] [Related]
10. Measurement of parathyroid hormone.
Endres DB; Villanueva R; Sharp CF; Singer FR
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone: radioimmunoassay and clinical interpretation.
Hawker CD
Ann Clin Lab Sci; 1975; 5(5):383-98. PubMed ID: 1180481
[TBL] [Abstract][Full Text] [Related]
12. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L
J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718
[TBL] [Abstract][Full Text] [Related]
15. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay.
Blind E; Schmidt-Gayk H; Scharla S; Flentje D; Fischer S; Göhring U; Hitzler W
J Clin Endocrinol Metab; 1988 Aug; 67(2):353-60. PubMed ID: 3292561
[TBL] [Abstract][Full Text] [Related]
16. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide.
Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE
J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381
[TBL] [Abstract][Full Text] [Related]
18. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
19. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
Nussbaum SR; Potts JT
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
[TBL] [Abstract][Full Text] [Related]
20. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
